CYTOKINETICS INC (CYTK) 40.49 -0.37 (-0.91%)
40.49 -0.37 (-0.91%)
US23282W6057 - Common Stock - After market: 40.49 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 69.75. This target is 72.27% above the current price.
CYTK was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CYTK.
In the previous month the buy percentage consensus was at a similar level.
CYTK was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-10-11 | UBS | Initiate | Buy |
| 2022-10-03 | JMP Securities | Maintains | Market Outperform |
| 2022-08-05 | Raymond James | Maintains | Outperform |
| 2022-07-15 | Morgan Stanley | Maintains | Overweight |
| 2022-06-10 | Piper Sandler | Maintains | Overweight |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-05-16 | Mizuho | Maintains | Buy |
| 2022-05-05 | Needham | Maintains | Buy |
| 2022-04-29 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-22 | Oppenheimer | Initiate | Outperform |
| 2021-12-21 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-10 | JP Morgan | Initiate | Overweight |
| 2021-12-01 | Mizuho | Maintains | Buy |
| 2021-11-04 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-08 | Morgan Stanley | Maintains | Overweight |
| 2021-10-07 | Jefferies | Initiate | Buy |
| 2021-08-06 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-20 | Barclays | Maintains | Overweight |
| 2021-07-19 | Needham | Maintains | Buy |
| 2021-07-19 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-19 | Morgan Stanley | Maintains | Overweight |
| 2021-03-12 | Wolfe Research | Initiate | Outperform |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA